GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » PE Ratio

BIO.B (Bio-Rad Laboratories) PE Ratio : At Loss (As of Dec. 14, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-14), Bio-Rad Laboratories's share price is $337.075. Bio-Rad Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-27.33. Therefore, Bio-Rad Laboratories's PE Ratio for today is At Loss.

During the past 13 years, Bio-Rad Laboratories's highest PE Ratio was 472.72. The lowest was 0.00. And the median was 24.81.

Bio-Rad Laboratories's EPS (Diluted) for the three months ended in Sep. 2024 was $23.34. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-27.33.

As of today (2024-12-14), Bio-Rad Laboratories's share price is $337.075. Bio-Rad Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $10.51. Therefore, Bio-Rad Laboratories's PE Ratio without NRI ratio for today is 32.07.

During the past 13 years, Bio-Rad Laboratories's highest PE Ratio without NRI was 110.75. The lowest was 23.76. And the median was 46.61.

Bio-Rad Laboratories's EPS without NRI for the three months ended in Sep. 2024 was $2.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $10.51.

During the past 12 months, Bio-Rad Laboratories's average EPS without NRI Growth Rate was -7.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 3.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 23.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.40% per year.

During the past 13 years, Bio-Rad Laboratories's highest 3-Year average EPS without NRI Growth Rate was 186.10% per year. The lowest was -53.30% per year. And the median was 11.20% per year.

Bio-Rad Laboratories's EPS (Basic) for the three months ended in Sep. 2024 was $23.37. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was $-27.28.

Back to Basics: PE Ratio


Bio-Rad Laboratories PE Ratio Historical Data

The historical data trend for Bio-Rad Laboratories's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories PE Ratio Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.35 4.61 5.37 At Loss At Loss

Bio-Rad Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Bio-Rad Laboratories's PE Ratio

For the Medical Devices subindustry, Bio-Rad Laboratories's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's PE Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's PE Ratio falls into.



Bio-Rad Laboratories PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Bio-Rad Laboratories's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=337.075/-27.330
=-12.33(At Loss)

Bio-Rad Laboratories's Share Price of today is $337.075.
Bio-Rad Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-27.33.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Bio-Rad Laboratories  (NYSE:BIO.B) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Bio-Rad Laboratories PE Ratio Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.